Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients

Journal of the American Society of Nephrology : JASN
Aníbal FerreiraSevelamer Study Group

Abstract

Disturbances in mineral metabolism play a central role in the development of renal bone disease. In a 54-wk, randomized, open-label study, 119 hemodialysis patients were enrolled to compare the effects of sevelamer hydrochloride and calcium carbonate on bone. Biopsy-proven adynamic bone disease was the most frequent bone abnormality at baseline (59%). Serum phosphorus, calcium, and intact parathyroid hormone were well controlled in both groups, although calcium was consistently lower and intact parathyroid hormone higher among patients who were randomly assigned to sevelamer. Compared with baseline values, there were no changes in mineralization lag time or measures of bone turnover (e.g., activation frequency) after 1 yr in either group. Osteoid thickness significantly increased in both groups, but there was no significant difference between them. Bone formation rate per bone surface, however, significantly increased from baseline only in the sevelamer group (P = 0.019). In addition, of those with abnormal microarchitecture at baseline (i.e., trabecular separation), seven of 10 in the sevelamer group normalized after 1 yr compared with zero of three in the calcium group. In summary, sevelamer resulted in no statistically signi...Continue Reading

Associated Clinical Trials

References

Dec 1, 1987·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·A M ParfittR R Recker
Feb 1, 1984·Journal of Clinical Pathology·J DentonJ Ball
Oct 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Q QiH H Malluche
Jan 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Y PeiD Sherrard
Mar 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J BraunF C Luft
Jan 1, 1996·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M C Monier-Faugere, H H Malluche
Nov 14, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M M CouttenyeM E De Broe
Sep 12, 2000·The American Journal of the Medical Sciences·J B Cannata Andía
Jun 26, 2002·Kidney International·Glenn M ChertowUNKNOWN Treat to Goal Working Group
Mar 13, 2003·Kidney International·Maarten W TaalMichael J D Cassidy
Aug 26, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Gérard M LondonHasan Adda
Feb 26, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kevin J MartinUNKNOWN Bone Turnover Work Group
Mar 23, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Teresa AdragaoAcácio Pita Negrao
May 6, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hartmut H MallucheMarie-Claude Monier-Faugere
Jun 24, 2004·Journal of the American Society of Nephrology : JASN·Gérard M LondonMarie-Christine de Vernejoul
Feb 25, 2005·Journal of the American Society of Nephrology : JASN·Ming TengRavi Thadhani
Apr 13, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Paolo RaggiGlenn M Chertow
Jun 3, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hans-Gernot AsmusJürgen Bommer

❮ Previous
Next ❯

Citations

Aug 22, 2012·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M R AllenS M Moe
May 10, 2013·Wiener medizinische Wochenschrift·Daniel Cejka
Oct 7, 2008·International Urology and Nephrology·David J A Goldsmith, Adrian Covic
Apr 30, 2013·Drugs·Fabio Malberti
Apr 9, 2010·The New England Journal of Medicine·Marcello TonelliBraden Manns
Aug 17, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Gulay AsciHartmut H Malluche
Sep 11, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·David J A GoldsmithRaymond Vanholder
Jun 28, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Igor G NikolovZiad A Massy
Nov 1, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jorge B Cannata-AndiaKeith Hruska
Dec 17, 2008·Current Opinion in Rheumatology·Thomas Bardin, Pascal Richette
May 9, 2009·Current Opinion in Nephrology and Hypertension·João M Frazão, Patrícia Martins
Jan 16, 2013·Current Opinion in Nephrology and Hypertension·Marta ChristovKate Wesseling-Perry
Sep 6, 2012·Southern Medical Journal·Veeraish ChauhanMegha Vaid
Jun 25, 2008·Seminars in Dialysis·Nicola MarangonPeter Stenvinkel
Mar 25, 2010·Seminars in Dialysis·Nigel D ToussaintPeter G Kerr
Feb 18, 2011·Seminars in Dialysis·Wajeh Qunibi, Kamyar Kalantar-Zadeh
Feb 23, 2011·Seminars in Dialysis·John T DaugirdasUNKNOWN Frequent Hemodialysis Network Trial Group
Oct 5, 2011·Seminars in Dialysis·James Goya HeafPeter Marckmann
Oct 12, 2011·Annals of Nutrition & Metabolism·Sophie Brunner-ZieglerJohannes Zsifkovits
May 5, 2012·Nephron. Clinical Practice·João M Frazão, Teresa Adragão
Sep 12, 2013·Nephron. Clinical Practice·Indranil DasguptaUNKNOWN NICE Hyperphosphataemia Guideline Development Group
Dec 20, 2012·Therapeutic Advances in Chronic Disease·Mario CozzolinoMaurizio Gallieni
Aug 4, 2012·Journal of the American Society of Nephrology : JASN·Susan C SchiaviYves Sabbagh
Aug 29, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Carol MooreYahya Osman-Malik
Jan 23, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Teresa AdragaoHartmut H Malluche
Nov 5, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Katherine Wesseling-PerryIsidro B Salusky
Dec 18, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Daniel CejkaHartmut H Malluche
Jun 22, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Adrian CovicAngel L M de Francisco
Jul 30, 2014·Néphrologie & thérapeutique·Ziad A Massy, Julien Maizel
Sep 17, 2015·Expert Opinion on Pharmacotherapy·Goce Spasovski
Nov 13, 2013·Expert Opinion on Pharmacotherapy·Makrouhi SonikianDimitrios S Goumenos
Oct 25, 2011·Expert Opinion on Pharmacotherapy·Fellype Carvalho BarretoVanda Jorgetti
Nov 18, 2015·Expert Opinion on Drug Metabolism & Toxicology·Amy Barton PaiNicole Wegrzyn
Aug 20, 2014·Expert Opinion on Drug Safety·Sushant Ramdas Taksande, Elaine M Worcester
Oct 28, 2010·Expert Opinion on Pharmacotherapy·Patrick Biggar, Markus Ketteler
Dec 17, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Leena PatelGrahame J Elder
Jan 26, 2016·Kidney International·Tilman B Drüeke, Ziad A Massy
Dec 1, 2009·Kidney International. Supplement·Vincent M BrandenburgMarkus Ketteler
Mar 17, 2011·Advances in Chronic Kidney Disease·Donald A Molony, Brett W Stephens
Apr 18, 2009·Seminars in Nephrology·Susan M Ott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.